Alventa Pharma Limited - Company Profile

Q: Who are the current directors of Alventa Pharma Limited?

The current directors of Alventa Pharma Limited are Anand Kumar Parmanandka, Rubi Mukhopadhyay, Biswajit Pan.

It is a pharma public limited company based in Kolkata, West Bengal, India, established in 2016.

2016 Kolkata, West Bengal, India Active

Last Updated: January 06, 2026

About Alventa Pharma Limited

Alventa Pharma Limited, a active public limited company, was established on 28 October 2016 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299WB2016PLC225674. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹3.51 M.

Formerly known as Elder Labs Private Limited. It upholds a compliant status. Its leadership includes Anand Kumar Parmanandka (Additional Director), Rubi Mukhopadhyay (Director), Biswajit Pan (Director). Past directors included Jeet Narain Singh, Aarti Sharma, Ramdeo Ram. It holds ₹30.00 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Room No.79 & 80, 3Rd Floor, At 55, Biplabi Rash Behari Basu Road (Mehta Building), Kolkata, West Bengal, 700001.

Company Details

CIN/LLPIN
U24299WB2016PLC225674
Registration Number
225674
Incorporation Date
28 October 2016
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹3.51 M
ROC Code
Roc Kolkata
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 06-01-2026
Paid Up Capital ₹ 3.51 M as on 06-01-2026
Company Age 9 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 30.00 Cr as on 06-01-2026
Revenue Growth **** 53.21% (FY 2023)
Profit Growth **** 114.76% (FY 2023)
Ebitda **** 87.43% (FY 2023)
Net Worth 754.96% (FY 2023)
Total Assets **** 60.88% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Alventa Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Alventa Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Anand Kumar Parmanandka	Additional Director	29 Apr 2018	Current
Rubi Mukhopadhyay	Director	04 Jun 2018	Current
Biswajit Pan	Director	07 Jun 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Jun 2019	Past
Pramod Abcsdd	Director	04 Jun 2018	Past
Pramod Abcsdd	Director	30 Apr 2018	Past
Pramod Abcsdd	Director	08 Jun 2019	Past
Pramod Abcsdd	Director	21 Jun 2018	Past
Pramod Abcsdd	Nominee Director	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alventa Pharma.

Alventa Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.21% increase. The company also saw a substantial improvement in profitability, with a 114.76% increase in profit. The company's net worth Soared by an impressive increase of 754.96%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

53.21%

*******

Revenue from Operations

*******

57.95%

*******

Total Assets

*******

60.88%

*******

Profit or Loss

*******

114.76%

*******

Net Worth

*******

754.96%

*******

EBITDA

*******

87.43%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alventa Pharma?

In 2022, Alventa Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹300,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 20.00 Cr
Indian Bank : 10.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
04 Nov 2025	Others	₹20.00 Cr	Open
22 Dec 2023	Indian Bank	₹10.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Alventa Pharma?

Unlock and access historical data on people associated with Alventa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Alventa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alventa Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alventa Pharma

Recent Activity within the Organization

Charges

A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101189989 was registered on 04 Nov 2025. was recorded as a recent event.
04 Nov 2025
Annual General Meeting

The activity Alventa Pharma Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
29 Sep 2025
Balance Sheet

Alventa Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.
31 Mar 2025
Charges

Progress on A charge with Indian Bank amounted to Rs. 10.00 Cr with Charge ID 100833805 was registered on 22 Dec 2023. was documented.
22 Dec 2023
Director Appointment

Progress on Biswajit Pan was appointed as a Director was appointed as a Director on 07 Jun 2019 & has been associated with this company since 6 years 8 months . was documented.
07 Jun 2019
Director Appointment

Progress on Rubi Mukhopadhyay was appointed as a Director was appointed as a Director on 04 Jun 2018 & has been associated with this company since 7 years 8 months . was documented.
04 Jun 2018

Explore recent activity and updates - View Recent Activity